Chapter 31 Chapter 31 Clinical and Epidemiological Studies: Skeletal Changes across Menopause Copyright © 2013 Elsevier Inc. All rights reserved.

Slides:



Advertisements
Similar presentations
Preventing Bone Loss in Early Postmenopausal Women A CME Slide Library From the Council on Hormone Education.
Advertisements

1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 4.1 Chapter 4.
Chapter 68 Chapter 68 Fracture Risk Assessment: The Development and Application of FRAX ® Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 62 Chapter 62 Mechanisms of Bone Destruction in Myeloma Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 85 Chapter 85 Parathyroid Hormone Treatment for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 6.1 Chapter 6.
Chapter 77 Chapter 77 Estrogen and Estrogen Analogs for Prevention and Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
1 Chapter 69 - Clinical Disturbances of Phosphate Homeostasis Copyright © 2013 Elsevier Inc. All rights reserved.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 14.
1 Chapter 77 - Ischemic Renal Disease Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 83 Chapter 83 Denosumab for the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 72 Chapter 72 Calcium in the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 54 Chapter 54 HIV and Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.
Copyright © 2011 American Medical Association. All rights reserved.
Regulation of osteoblast (A) and osteoclast (B) development
Modeling Constraints with Parametrics
Copyright © 2016 Elsevier Inc. All rights reserved.
Chapter 41 Work-Related Musculo-Skeletal Disorders
Copyright © 2012, Elsevier Inc. All rights Reserved.
Chapter 11.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Chapter 10.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Selective Estrogen Receptor Modulators and Phytoestrogens: New Therapies for the Postmenopausal Woman  Lorraine A. Fitzpatrick, MD  Mayo Clinic Proceedings 
Copyright © 2013 Elsevier Inc. All rights reserved.
Estrogen and Bone: Osteoclasts Take Center Stage
Portable Biotechnology
© 2012 Elsevier, Inc. All rights reserved.
Modeling Text-Based Requirements and their Relationship to Design
Modeling Functionality with Use Cases
Copyright © 2012, Elsevier Inc. All rights Reserved.
M. Kathleen Clark, Ph. D. , MaryFran R. Sowers, Ph. D
Chapter 91 Epidemiology of Headache in Women:
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 12.
Chapter 6.
Copyright © 2012, Elsevier Inc. All rights Reserved.
© 2012 Elsevier, Inc. All rights reserved.
Chapter 103 Long-Term Care: The Global Impact
Chapter 01.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 08.
Chapter 64 - Renal Calcium Metabolism
© 2015 Elsevier, Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel  Filippo De Marinis, MD, Wilfried Eberhardt,
Copyright © 2015 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Chapter 15 Contraception
Chapter 29 - Stem Cells and Generation of New Cells in the
Figure 1. Cross talk between the immune system and osteoclasts in osteoclastogenesis. Osteoclasts are derived from monocyte precursor cells. RANKL from.
Does the menopausal transition affect health-related quality of life?
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 15.
Chapter 20 Assisted Reproductive Technologies
Chapter 3.
© 2015 Elsevier, Inc. All rights reserved.
Income elasticities (top panel) and own-price elasticities (bottom panel) for select food categories by income decile. Income elasticities (top panel)
Presentation transcript:

Chapter 31 Chapter 31 Clinical and Epidemiological Studies: Skeletal Changes across Menopause Copyright © 2013 Elsevier Inc. All rights reserved.

FIGURE 31.1 Working model of changes and potential time course of these changes in osteoclast/osteoblast apoptosis (A), in proresorptive cytokines (B), and in osteoblastogenesis, increases in T cells, and osteoclastogenesis (C) after the induction of estrogen deficiency (see text). IL: Interleukin; RANKL: Receptor activator of nuclear factor kappaB ligand; TNFα: Tumor necrosis factor α. Source: Khosla (2010) [8]. 2

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 31.2 Annual rate of change in bone mineral density (BMD) of the lumbar spine and total hip in premenopausal (red bars), early perimenopausal (blue bars), late perimenopausal (yellow bars), and postmenopausal (green bars) women (n = 1902). Rates of change were estimated from multivariable linear mixed models and adjusted for multiple covariates. Error bars represent 95% confidence intervals (CI). Comparisons were made across status categories: Early peri- vs. premenopausal, p < (spine) and p = (hip); late peri- vs. early perimenopausal, p < (spine) and p < (hip); and post- vs. late perimenopausal, p = (spine) and p < (hip). Source: Finkelstein et al. (2008) [21]. 3

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 31.3 Annual rate of change in bone mineral density (BMD) of the lumbar spine in premenopausal (red bars), early perimenopausal (blue bars), late perimenopausal (yellow bars), and postmenopausal (green bars) women from the full cohort. Source: Finkelstein et al. (2008) [20]. 4

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 31.4 Annual rate of change in bone mineral density (BMD) of the lumbar spine (top panel) and total hip (bottom panel) in premenopausal (red bars), early perimenopausal (blue bars), late perimenopausal (yellow bars), and postmenopausal (green bars) women divided by tertiles of baseline body weight (tertile 1, 77.3 kg) in the entire cohort. Rates of change were estimated from multivariable linear mixed models and adjusted for multiple covariates. Error bars represent 95% confidence intervals. Comparisons were made between tertile groups, with p values for lumbar spine in pre-, early peri-, late peri-, and postmenopausal women, respectively, as follows: tertile 1 vs. 3, <0.001, <0.001, <0.001, and <0.001; tertile 2 vs. 3, = 0.033, <0.001, <0.001, and <0.001; tertile 1 vs. = 2, 0.13, = 0.002, = 0.39, and = 0.044; and with P values for total hip in pre-, early peri-, late peri-, and postmenopausal women, respectively: tertile 1 vs. 3, = 0.15, <0.001, = 0.027, and <0.001; tertile 2 vs. 3, = 0.51, = 0.08, = 0.09, and <0.001; tertile 1 vs. 2, = 0.032, = 0.017, = 0.68, and = Source: Finkelstein et al. (2008) [20]. 5

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 31.5 Mean urine cross-linked N-telopeptide of type I collagen (NTx), serum estradiol (E2), and serum follicle-stimulating hormone (FSH) levels of the entire study population (n = 918) in relations to years from the final menstrual period. The dashed lines or the shaded areas denote the 95% confidence intervals. Source: Sowers et al. (2013) [37]. 6

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 31.6 Multivariable-adjusted hazard ratio (HR) and 95% confidence interval (CI) of fracture by baseline cross-linked N-telopeptide of type I collagen (NTx) and lumbar spine bone mineral density (BMD; p interaction = 0.32). fx, fracture. Source: Cauley et al. (2003) [6]. 7